4cxx

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
'''Unreleased structure'''
+
==Crystal structure of human FTO in complex with acylhydrazine inhibitor 16==
-
 
+
<StructureSection load='4cxx' size='340' side='right' caption='[[4cxx]], [[Resolution|resolution]] 2.76&Aring;' scene=''>
-
The entry 4cxx is ON HOLD until Paper Publication
+
== Structural highlights ==
-
 
+
<table><tr><td colspan='2'>[[4cxx]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4CXX OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4CXX FirstGlance]. <br>
-
Authors: Toh, D.W., Sun, L., Tan, J., Chen, Y., Lau, L.Z.M., Hong, W., Woon, E.C.Y., Gao, Y.G.
+
</td></tr><tr><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=640:4-(2-{[4-(4-TERT-BUTYLBENZYL)PYRIDIN-3-YL]CARBONYL}HYDRAZINYL)-4-OXOBUTANOIC+ACID'>640</scene>, <scene name='pdbligand=NI:NICKEL+(II)+ION'>NI</scene><br>
-
 
+
<tr><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4cxw|4cxw]], [[4cxy|4cxy]], [[4cxz|4cxz]], [[4cy0|4cy0]]</td></tr>
-
Description: Oxidoreductase Complex 2
+
<tr><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4cxx FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4cxx OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4cxx RCSB], [http://www.ebi.ac.uk/pdbsum/4cxx PDBsum]</span></td></tr>
 +
<table>
 +
== Disease ==
 +
[[http://www.uniprot.org/uniprot/FTO_HUMAN FTO_HUMAN]] Defects in FTO are the cause of growth retardation developmental delay coarse facies and early death (GDFD) [MIM:[http://omim.org/entry/612938 612938]]. A severe polymalformation syndrome characterized by postnatal growth retardation, microcephaly, severe psychomotor delay, functional brain deficits and characteristic facial dysmorphism. In some patients, structural brain malformations, cardiac defects, genital anomalies, and cleft palate are observed. Early death occurs by the age of 3 years.<ref>PMID:19559399</ref>
 +
== Function ==
 +
[[http://www.uniprot.org/uniprot/FTO_HUMAN FTO_HUMAN]] Dioxygenase that repairs alkylated DNA and RNA by oxidative demethylation. Has highest activity towards single-stranded RNA containing 3-methyluracil, followed by single-stranded DNA containing 3-methylthymine. Has low demethylase activity towards single-stranded DNA containing 1-methyladenine or 3-methylcytosine. Has no activity towards 1-methylguanine. Has no detectable activity towards double-stranded DNA. Requires molecular oxygen, alpha-ketoglutarate and iron. Contributes to the regulation of the global metabolic rate, energy expenditure and energy homeostasis. Contributes to the regulation of body size and body fat accumulation.<ref>PMID:18775698</ref> <ref>PMID:20376003</ref>
 +
== References ==
 +
<references/>
 +
__TOC__
 +
</StructureSection>
 +
[[Category: Chen, Y.]]
 +
[[Category: Gao, Y G.]]
 +
[[Category: Hong, W.]]
 +
[[Category: Lau, L Z.M.]]
 +
[[Category: Sun, L.]]
 +
[[Category: Tan, J.]]
 +
[[Category: Toh, D W.]]
 +
[[Category: Woon, E C.Y.]]
 +
[[Category: Oxidoreductase]]
 +
[[Category: Small molecular probe]]

Revision as of 00:21, 2 October 2014

Crystal structure of human FTO in complex with acylhydrazine inhibitor 16

4cxx, resolution 2.76Å

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Views
Personal tools
Navigation
Toolbox